Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-24
DOI
10.3389/fmicb.2021.790686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Eltrombopag as a Repurposing Drug Against Staphylococcus epidermidis and its Biofilms
- (2021) Juan Zhu et al. CURRENT MICROBIOLOGY
- Eltrombopag directly inhibits BAX and prevents cell death
- (2021) Adam Z. Spitz et al. Nature Communications
- A Deep Learning Approach to Antibiotic Discovery
- (2020) Jonathan M. Stokes et al. CELL
- Proton Motive Force Disruptors Block Bacterial Competence and Horizontal Gene Transfer
- (2020) Arnau Domenech et al. Cell Host & Microbe
- Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
- (2020) Yunlei Guo et al. Frontiers in Cellular and Infection Microbiology
- Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria
- (2020) Yuan Liu et al. Advanced Science
- Repurposing Antispasmodic Agent Otilonium Bromide for Treatment of Staphylococcus aureus Infections
- (2020) Linying Zhou et al. Frontiers in Microbiology
- Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication
- (2020) Torin Waters et al. BMC CANCER
- Preparation and Solid-State Characterization of Eltrombopag Crystal Phases
- (2020) Vincenzo Mirco Abbinante et al. MOLECULES
- Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies
- (2019) Dina Raafat et al. TRENDS IN MICROBIOLOGY
- 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain
- (2019) Albert Byungyun Jeon et al. Scientific Reports
- Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus
- (2019) Shuofeng Yuan et al. Viruses-Basel
- Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent
- (2019) Hao-Tai Ko et al. MEDICAL MYCOLOGY
- Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models
- (2019) Meng Su et al. MOLECULAR PHARMACEUTICS
- A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus
- (2019) Wooseong Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibacterial properties and in vivo efficacy of a novel nitrofuran, IITR06144, against MDR pathogens
- (2019) Timsy Bhando et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles
- (2019) Basem Battah et al. MOLECULES
- Mechanisms and therapeutic prospects of thrombopoietin receptor agonists
- (2019) James Bussel et al. SEMINARS IN HEMATOLOGY
- Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis
- (2019) Pengfei She et al. Frontiers in Microbiology
- The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
- (2019) Jens-Uwe Vogel et al. Cells
- Staphylococcus aureusbiofilms release leukocidins to elicit extracellular trap formation and evade neutrophil-mediated killing
- (2018) Mohini Bhattacharya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Methicillin-resistant Staphylococcus aureus
- (2018) Andie S. Lee et al. Nature Reviews Disease Primers
- A high rate of ceftobiprole resistance among clinical MRSA from a hospital in central Italy
- (2018) Gianluca Morroni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteers
- (2018) Vassilios Aslanis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
- (2018) Sahreena Lakhundi et al. CLINICAL MICROBIOLOGY REVIEWS
- A new class of synthetic retinoid antibiotics effective against bacterial persisters
- (2018) Wooseong Kim et al. NATURE
- A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants
- (2018) Ryan P. Trombetta et al. mSphere
- Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
- (2016) Renchi Yang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Revealing eltrombopags promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation
- (2016) C. A. Di Buduo et al. HAEMATOLOGICA
- Revealing eltrombopags promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation
- (2016) C. A. Di Buduo et al. HAEMATOLOGICA
- Eltrombopag for treatment of thrombocytopenia-associated disorders
- (2015) Pietro Merli et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Eltrombopag antitumor effect on hepatocellular carcinoma
- (2015) TOMOHIRO KUROKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The crisis of no new antibiotics—what is the way forward?
- (2011) Laura JV Piddock LANCET INFECTIOUS DISEASES
- Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag
- (2010) Connie L. Erickson-Miller et al. LEUKEMIA RESEARCH
- Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
- (2008) Connie L. Erickson-Miller et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now